Global  

Oxford-AstraZeneca vaccine showing effectiveness in older adults

CBS News Friday, 20 November 2020 ()
Progress is quickly being made in the race for a coronavirus vaccine. AstraZeneca says the vaccine it is developing at Oxford University in London is highly effective in older adults. This is the third vaccine to show promise in recent weeks, and it could be available alongside the vaccines being developed by Pfizer and Moderna. Charlie D'Agata discusses how the AstraZeneca vaccine differs from the other two.
0
shares
ShareTweetSavePostSend
 
Video Credit: PA - Press Association STUDIO - Published
News video: Oxford Covid-19 vaccine produces strong immune response in older adults – study

Oxford Covid-19 vaccine produces strong immune response in older adults – study 01:10

The University of Oxford is expected to release data on the effectiveness ofits coronavirus vaccine in the coming weeks, with the latest trial resultssuggesting it produces a strong immune response in older adults. The ChAdOx1nCov-2019 vaccine has been shown to trigger a robust immune response...

💡 One News Page Knowledge: Other News Mentions

AstraZeneca British-Swedish pharmaceutical company

Gujarat: PM Modi reviews vaccine development at Zydus Cadila facility

Prime Minister Narendra Modi on Saturday began his three-city visit to review coronavirus vaccine development work by going to pharma major Zydus Cadila's..
IndiaTimes
Wall Street too giddy over vaccines: economist [Video]

Wall Street too giddy over vaccines: economist

Spartan Capital Securities chief market economist Peter Cardillo tells Reuters Fred Katayama investors are overly optimistic on the impact of vaccines as AstraZeneca's trial data comes under question. He also provides his view on retailers' prospects for the holiday shopping season.

Credit: Reuters Studio    Duration: 05:13Published
Nations press on with AstraZeneca vaccine amid concerns [Video]

Nations press on with AstraZeneca vaccine amid concerns

Britain asked its regulator on Friday to assess AstraZeneca's COVID-19 vaccine for a possible rollout, while the Philippines and Thailand secured millions of doses, giving the shot a vote of confidence after experts raised questions about trial data. Emer McCarthy reports.

Credit: Reuters Studio    Duration: 02:01Published
Government could face ‘tough choices’ over vaccines [Video]

Government could face ‘tough choices’ over vaccines

The Government could face some “tough choices” if the vaccine produced byAstraZeneca and Oxford University is found to be less effective than others, aformer Department of Health director of immunisation has said. Professor DavidSalisbury said ministers would need to think “very carefully” about theirhandling of the vaccine if its efficacy was lower than for other jabs such asthose from Pfizer/BioNTech and Moderna. The AstraZeneca/Oxford vaccine iscurrently being assessed by the Medicines and Healthcare products RegulatoryAgency (MHRA) for use in the UK.Data from two arms of its phase-three trial,announced last week, gave a combined efficacy of 70%.

Credit: PA - Press Association STUDIO    Duration: 00:59Published
Astrazeneca Covid-19 vaccine: Company to run new tests amid fresh doubts [Video]

Astrazeneca Covid-19 vaccine: Company to run new tests amid fresh doubts

Credit: FRANCE 24 English    Duration: 01:33Published

University of Oxford University of Oxford Collegiate research university in Oxford, England

AstraZeneca Admits COVID Breakthrough Came From Mistake [Video]

AstraZeneca Admits COVID Breakthrough Came From Mistake

AstraZeneca and the University of Oxford are facing criticism over their COVID-19 vaccine trial results. According to Business Insider the criticism comes after AstraZeneca admitted to a mistake in the vaccine dosage. During the vaccine trial, some patients got two full doses of the vaccine. Others had a half-dose in their first shot, followed by a full dose. On Wednesday, an AstraZeneca executive described the "mistake" as "serendipity.

Credit: Wochit News    Duration: 00:36Published
Dosing Mix-up Raises Questions About New COVID Vaccine [Video]

Dosing Mix-up Raises Questions About New COVID Vaccine

A manufacturing error is raising concerns about a promising COVID-19 vaccine being developed. The vaccine was developed by pharmaceutical company AstraZeneca and the University of Oxford. Less than a week after we learned about it, the developers have admitted to a manufacturing error. The error resulted from two different doses during the recently concluded phase III trial. AstraZeneca and the University of Oxford described the vaccine as being 70% effective.

Credit: Wochit News    Duration: 00:39Published

Expert sees "nothing sinister" amid questions over vaccine's data

AstraZeneca and Oxford University acknowledged a manufacturing error that raised questions about preliminary results of their experimental COVID-19 vaccine.
CBS News

London London Capital of the United Kingdom

Michel Barnier arrives in London ahead of trade talks resuming [Video]

Michel Barnier arrives in London ahead of trade talks resuming

EU chief negotiator Michel Barnier has arrived in London ahead of face-to-facetalks in a bid to reach a Brexit deal. Mr Barnier was pictured wearing a maskas he left St Pancras International station in central London, waving to themedia as he left in a car.

Credit: PA - Press Association STUDIO    Duration: 00:52Published

Brexit: Barnier arrives in UK for face-to-face talks

The EU's Michel Barnier arrived in London on Friday evening, as the two sides try to agree a deal.
BBC News
Floral bodysuit worn by Lady Gaga to go under the hammer in London [Video]

Floral bodysuit worn by Lady Gaga to go under the hammer in London

A “spectacular” 10ft floral bodysuit worn by Lady Gaga in her latest musicvideo could sell for as much as £20,000 next month in London. The pop star,34, wore the hand-painted and appliqued leather bodysuit, called the FloralAlien, during the shoot for the song 911 which was filmed in the desert regionof Valencia in California this August.

Credit: PA - Press Association STUDIO    Duration: 01:16Published

Ecclestone burglary trial: Accused 'was in London for client'

Maria Mester was paid to spend the week in the city as part of her work as an escort, a court hears.
BBC News

Memorial garden for Covid-19 victims

The 33 blossoming trees – one for each London borough - will form the centrepiece of the garden.
BBC News

Charlie D'Agata Charlie D'Agata

Oxford-AstraZeneca coronavirus vaccine trial shows up to 90% effectiveness

The coronavirus vaccine being developed by AstraZeneca and the University of Oxford is up to 90% effective in preventing the disease, with clinical trials also..
CBS News

ER doctor discusses AstraZeneca's COVID-19 vaccine and a new antibody treatment

With one week left in November, the U.S. has already seen its highest monthly coronavirus case total. This comes as AstraZeneca announced that trials show its..
CBS News

AstraZeneca-Oxford COVID-19 vaccine up to 90% effective, late stage trials show

Another potential coronavirus vaccine is showing promising results. Charlie D'Agata reports from Oxford University in England on the AstraZeneca vaccine trial.
CBS News

Phase 2 results of Oxford, AstraZeneca vaccine trial show promising results

Scientists in England say the latest results of the Oxford COVID-19 vaccine show it's safe and provokes an immune response. It joins a growing list of vaccine..
CBS News

Moderna Moderna American biotechnology company

Moderna's COVID-19 Vaccine Designed Designed In 2 Days [Video]

Moderna's COVID-19 Vaccine Designed Designed In 2 Days

Moderna's coronavirus vaccine candidate is 94.5% effective at protecting people against COVID-19. The candidate took under a year to develop and test, which is years faster than previous vaccines. The company designed its vaccine candidate in just two days, says Business Insider. In contrast, traditional vaccines can take years to design. Vaccines will hopefully be rolled out by Spring of 2021.

Credit: Wochit News    Duration: 00:33Published
Doctors Say CDC Should Warn People About COVID-19 Vaccine Side Effects [Video]

Doctors Say CDC Should Warn People About COVID-19 Vaccine Side Effects

Now that Pfizer, Moderna and AstraZeneca are each closer to releasing a COVID-19 vaccine to the public.

Credit: Cover Video STUDIO    Duration: 01:21Published
Coronavirus pandemic: EU annouces latest vaccine contact with Moderna [Video]

Coronavirus pandemic: EU annouces latest vaccine contact with Moderna

Credit: FRANCE 24 English    Duration: 01:23Published

Pfizer Pfizer Multinational pharmaceutical corporation

Covid 19 coronavirus: The Conversation: Why the Oxford AstraZeneca vaccine is now a global game changer

In the long, dark tunnel that has been 2020, November stands out as the month that light appeared. Some might see it as a bright light, others as a faint light..
New Zealand Herald

Sputnik’s ‘efficacy at 95%’, to be cheaper than US vaccines

Russia’s Sputnik V Covid-19 vaccine, that reported an efficacy of over 95%, will be twice as cheap as those by Pfizer and Moderna with similar positive..
IndiaTimes

You Might Like


Related videos from verified sources

Covid-19: ‘Can vaccinate everyone in Delhi within weeks’, says Satyendar Jain [Video]

Covid-19: ‘Can vaccinate everyone in Delhi within weeks’, says Satyendar Jain

Health Minister Satyendar Jain on Friday said Delhi has sufficient infrastructure and equipment to vaccinate its entire population in a few weeks once a COVID-19 vaccine is available."There is no need..

Credit: HT Digital Content     Duration: 03:15Published
Oxford Astra Zeneca's vaccine error | What happens to India trials? | Oneindia News [Video]

Oxford Astra Zeneca's vaccine error | What happens to India trials? | Oneindia News

Even as Oxford and Astra Zeneca said that their Covid-19 vaccine had a 90% efficacy, their claims it turned out were based on an accident. Oxford Astrazeneca said that when volunteers were administered..

Credit: Oneindia     Duration: 01:25Published
Questions over AstraZeneca's COVID-19 vaccine data [Video]

Questions over AstraZeneca's COVID-19 vaccine data

British drugmaker AstraZeneca is working with regulators to investigate a lower dosage of its vaccine that performed better than a full dosage, a spokesman for the company said on Thursday, after its..

Credit: Reuters - Politics     Duration: 01:29Published

Related news from verified sources

Africa: Which Covid-19 Vaccine Could Reach Developing Countries First?

[Thomson Reuters Foundation] Pfizer, Moderna and AstraZeneca vaccines could be rolled out early next year. We asked experts to explain the key differences, and...
allAfrica.com Also reported by •Mid-DayThe VergeNewsyProactive Investors

Pfizer And Moderna Vaccines: Here’s Everything We Know So Far – Analysis

By Nikhila Natarajan After a 10 month long wait, vaccine news is moving at a phenomenal clip. In the span of 7 days after the US election results, two US...
Eurasia Review

BMC identifies three storage spaces for COVID-19 vaccine when ready

BMC identifies three storage spaces for COVID-19 vaccine when ready
The civic body has identified three of its own properties, of which one will be converted into a Central Storage Facility for COVID-19 vaccines. The BMC aims to...
Mid-Day Also reported by •Eurasia ReviewNewsyThe Verge